No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
RCE Recce Pharmaceuticals Ltd
- 0.480
- 0.0000.00%
20min DelayMarket Closed Jan 16 14:20 AET
111.30MMarket Cap-4.80P/E (Static)
0.480High0.470Low11.97KVolume0.480Open0.480Pre Close5.71KTurnover0.69552wk High0.01%Turnover Ratio231.87MShares0.38052wk Low-0.1EPS TTM74.55MFloat Cap1.875Historical HighLossP/E (Static)155.31MShs Float0.130Historical Low-0.1EPS LYR2.08%Amplitude--Dividend TTM-11.71P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Investors in Recce Pharmaceuticals (ASX:RCE) Have Seen Notable Returns of 68% Over the Past Five Years
Recce Pharmaceuticals Secures Australian Patent for Anti-infectives; Covered in All Major Markets
Complete Patent Protection for 2 Recce Anti-infective Treatments
Recce Pharmaceuticals Obtains Australian Patent for Anti-Infectives
Recce Scores $6.75M R&D Rebate
Recce Pharmaceuticals Receives A$6.75 Million R&D Tax Incentive Rebate | ASX:RCE, OTC:RECEF
Heat List
AU
Overall
Symbol
Price
% Chg
No Data